A study to evaluate XMT-1536 in cancer treatment
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2017
At a glance
- Drugs XMT 1536 (Primary)
- Indications Cancer; Non-small cell lung cancer
- Focus Adverse reactions
- 09 Mar 2017 According to a Mersana Therapeutics media release, company expects clinical development of XMT-1536 in early 2018.
- 09 Dec 2016 New trial record
- 05 Dec 2016 According to a Mersana Therapeutics media release, the company anticipates to initiate this study later in the year 2017.